Ultrasound to check duct closure in premature babies
Part of Genetic & congenital, Heart & circulation clinical trials.
This study uses ultrasound to see if a heart blood vessel called the ductus arteriosus has closed after treatment in premature infants. It aims to find a better way to monitor the response to treatment without X-rays.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Newborn less than 28 days old
- Has a heart vessel that needs closing treatment (based on usual care)
- Does not have any other major heart defects besides the open duct and a common small opening
- Does not have a collapsed lung (pneumothorax)
- Does not have bleeding in the lungs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses ultrasound images of the lungs to see if doctors can predict which very premature babies will develop bronchopulmonary dysplasia (BPD)—a chronic lung condition common in extremely premature infants. The goal is to identify at-risk babies early so they can receive targeted treatment.
This trial compares an early procedure to close a heart vessel called the ductus arteriosus versus careful observation alone in very low-birth-weight preterm infants. It aims to see whether closing the vessel early can improve outcomes and be done safely.
This study looks at how well children do when their PDA is closed using a catheter (a thin tube through a blood vessel). It helps doctors understand the best ways to treat this common heart condition in kids ages 6 months to 16 years.
This study keeps a national record of babies with a heart connection called a PDA who are being considered for closure using a catheter procedure. It may help doctors improve how they choose treatment and devices for babies with different health needs.
This study checks how well and how safely the Occlutech PDA Occluder works over time to close a patent ductus arteriosus (PDA). You may be considered if your PDA can be treated with this non-surgical device and you can return for follow-up visits.
This trial studies whether giving medicine soon can help preterm babies with a patent ductus arteriosus (a temporary leaking blood vessel in the heart). It aims to see if early treatment improves outcomes for very early gestational age infants.
Hear when a new Patency of the Ductus Arteriosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.